Sanofi
SNY
492 hedge funds and large institutions have $12.7B invested in Sanofi in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 189 increasing their positions, 151 reducing their positions, and 41 closing their positions.
157% more call options, than puts
Call options by funds: $46.8M | Put options by funds: $18.2M
25% more repeat investments, than reductions
Existing positions increased: 189 | Existing positions reduced: 151
2% more capital invested
Capital invested by funds: $12.4B → $12.7B (+$281M)
0.15% more ownership
Funds ownership: 17.98% → 18.13% (+0.15%)
1% less funds holding
Funds holding: 496 → 492 (-4)
5% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 41
23% less funds holding in top 10
Funds holding in top 10: 13 → 10 (-3)
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$209M |
| 2 |
Neuberger Berman Group
New York
|
+$173M |
| 3 |
Harris Associates
Chicago,
Illinois
|
+$127M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$55.8M |
| 5 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$39.1M |
Top Sellers
SNY Hedge Fund Activity: Q2 2014 in Review
492 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2014, worth a combined $12.7B — up 2.3% from $12.4B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of SNY and 39 opened new positions — a net loss of 2 holders — while 151 trimmed existing stakes and 189 added.
The largest buyer was Franklin Resources, adding an estimated $209M. The largest seller was Boston Partners, cutting an estimated $259M.
- 492 institutional investors held Sanofi (SNY) as of Q2 2014, down from 496 in Q1 2014.
- Funds reported $12.7B of Sanofi stock for Q2 2014, up 2.3% quarter-over-quarter.
- 39 funds opened new Sanofi positions in Q2 2014 and 41 closed out, a net change of -2 holders.
- The largest Sanofi buyer in Q2 2014 was Franklin Resources, an estimated $209M added.
- The largest Sanofi seller in Q2 2014 was Boston Partners, an estimated $259M sold.
Based on aggregated 13F filings for Q2 2014.